Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton

By sjmartinez • August 15, 2023

Benhammou JN, Qiao B, Ko A, Sinnett-Smith J, Pisegna JR, Rozengurt E. Lipophilic statins inhibit YAP coactivator transcriptional activity in HCC cells through Rho-mediated modulation of actin cytoskeleton. Am J Physiol Gastrointest Liver Physiol. 2023 Sep 1;325(3):G239-G250. doi: 10.1152/ajpgi.00089.2023. Epub 2023 Jun 27. PMID: 37366601.

Tags: chemoprevention, Digestive Diseases, Hepatocellular carcinoma, Publications, statin, Veterans Administration, YAP

Efficacy and Safety of Ustekinumab and Vedolizumab for Crohn’s Disease of the Pouch

Park S, Keyashian K, Ho A, Limsui D, Frost S, Vazquez R, Yang E, Ebriani J, Maas L, Parian A, Lazarev M, Parekh N, Sauk[...]

Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American Society for Gastrointestinal Endoscopy preservation and incorporation of valuable endoscopic innovations thresholds for transoral outlet reduction

Jirapinyo P, Kumar N, Thompson CC, Law RJ, Muthusamy VR, Schulman AR, Sullivan S. Association for Bariatric Endoscopy systematic review and meta-analysis assessing the American[...]

ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease

Farraye FA, Melmed GY, Lichtenstein GR, Barnes EL, Limketkai BN, Caldera F, Kane S. ACG Clinical Guideline Update: Preventive Care in Inflammatory Bowel Disease. Am[...]